AU738966C - Modulators of body weight, corresponding nucleic acids and proteins, and diagnostic and therapeutic uses thereof - Google Patents

Modulators of body weight, corresponding nucleic acids and proteins, and diagnostic and therapeutic uses thereof

Info

Publication number
AU738966C
AU738966C AU57192/99A AU5719299A AU738966C AU 738966 C AU738966 C AU 738966C AU 57192/99 A AU57192/99 A AU 57192/99A AU 5719299 A AU5719299 A AU 5719299A AU 738966 C AU738966 C AU 738966C
Authority
AU
Australia
Prior art keywords
modulators
diagnostic
proteins
nucleic acids
body weight
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
AU57192/99A
Other versions
AU738966B2 (en
AU5719299A (en
Inventor
Stephen K. Burley
Jeffrey M Friedman
Ketan Gajiwala
Jeffrey L. Halaas
Margherita Maffei
Ricardo Proenca
Yiying Zhang
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Rockefeller University
Original Assignee
Rockefeller University
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from AU33298/95A external-priority patent/AU3329895A/en
Application filed by Rockefeller University filed Critical Rockefeller University
Priority to AU57192/99A priority Critical patent/AU738966C/en
Publication of AU5719299A publication Critical patent/AU5719299A/en
Application granted granted Critical
Publication of AU738966B2 publication Critical patent/AU738966B2/en
Publication of AU738966C publication Critical patent/AU738966C/en
Anticipated expiration legal-status Critical
Expired legal-status Critical Current

Links

AU57192/99A 1994-08-17 1999-11-03 Modulators of body weight, corresponding nucleic acids and proteins, and diagnostic and therapeutic uses thereof Expired AU738966C (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
AU57192/99A AU738966C (en) 1994-08-17 1999-11-03 Modulators of body weight, corresponding nucleic acids and proteins, and diagnostic and therapeutic uses thereof

Applications Claiming Priority (6)

Application Number Priority Date Filing Date Title
US292345 1994-08-17
US347563 1994-11-30
US438431 1995-05-10
US483211 1995-06-07
AU33298/95A AU3329895A (en) 1994-08-17 1995-08-17 Modulators of body weight, corresponding nucleic acids and proteins, and diagnostic and therapeutic uses thereof
AU57192/99A AU738966C (en) 1994-08-17 1999-11-03 Modulators of body weight, corresponding nucleic acids and proteins, and diagnostic and therapeutic uses thereof

Related Parent Applications (1)

Application Number Title Priority Date Filing Date
AU33298/95A Division AU3329895A (en) 1994-08-17 1995-08-17 Modulators of body weight, corresponding nucleic acids and proteins, and diagnostic and therapeutic uses thereof

Publications (3)

Publication Number Publication Date
AU5719299A AU5719299A (en) 2000-04-06
AU738966B2 AU738966B2 (en) 2001-10-04
AU738966C true AU738966C (en) 2003-04-10

Family

ID=3720737

Family Applications (1)

Application Number Title Priority Date Filing Date
AU57192/99A Expired AU738966C (en) 1994-08-17 1999-11-03 Modulators of body weight, corresponding nucleic acids and proteins, and diagnostic and therapeutic uses thereof

Country Status (1)

Country Link
AU (1) AU738966C (en)

Also Published As

Publication number Publication date
AU738966B2 (en) 2001-10-04
AU5719299A (en) 2000-04-06

Similar Documents

Publication Publication Date Title
GR970300021T1 (en) Modulators of body weight, corresponding nucleic acids and proteins, and diagnostic and therapeutic uses thereof
AU9383098A (en) Novel targeted contrast agents for diagnostic and therapeutic use
HUP9801207A3 (en) Therapeutic compositions for transfecting nucleic acids and use thereof
AU6763898A (en) Gel sensors and methods of use thereof
AU2809897A (en) Novel human cytomegalovirus dna constructs and uses therefor
AU2990695A (en) Mucin-derived proteins for the diagnosis, imaging, and therapy of human cancer
HK1043937A1 (en) Human therapeutic uses of bpi protein products
AU4553793A (en) Use of p97 and iron binding proteins as diagnostic and therapeutic agents
AU2749395A (en) Medical use of bromelain
AU6282896A (en) Gene therapy of solid tumors with interferons alone or with other immuno-effector proteins
AU2467395A (en) Novel ophthalmologic uses of protein c
AU4713497A (en) Use of hollow microcapsules in diagnosis and therapy
AU7136196A (en) Pharmaceutical composition which is useful for the transfection of nucleic acids, and uses thereof
AU2832195A (en) Nucleic acid-binding oligomers for therapy and diagnosis
AU3329895A (en) Modulators of body weight, corresponding nucleic acids and proteins, and diagnostic and therapeutic uses thereof
AU6582698A (en) Therapeutic uses of grip and grip-related molecules
AU738966C (en) Modulators of body weight, corresponding nucleic acids and proteins, and diagnostic and therapeutic uses thereof
AU7846000A (en) Novel human lipase proteins, nucleic acids encoding them, and uses of both of these
AU1712395A (en) Medical application of bromelain
AU5293198A (en) Promoter of the human endoglin gene and its use
TJ425B (en) Modulators of body weight, corresponding nucleic acids and proteins, and diagnostic and therapeutic uses thereof
AU3628697A (en) Lipid-binding proteins and their therapeutic and diagnostic use
AU1283395A (en) Variant protein of human dna topoisomerase i
AU5148998A (en) Osteometrin related peptides and nucleic acids and diagnosis and therapies using them
AU4595696A (en) Rna polymerase ii peptides and methods of use

Legal Events

Date Code Title Description
FGA Letters patent sealed or granted (standard patent)
DA2 Applications for amendment section 104

Free format text: THE NATURE OF THE PROPOSED AMENDMENT IS AS SHOWN IN THE STATEMENT(S) FILED 20020912

DA3 Amendments made section 104

Free format text: THE NATURE OF THE AMENDMENT IS AS WAS NOTIFIED IN THE OFFICIAL JOURNAL DATED 20021010